Buy CINGAL®

Cingal® is the first and only approved combination viscosupplement that delivers both cross-linked hyaluronic acid and a fast-acting corticosteroid (triamcinolone hexacetonide) in a single injection. 

This innovative product works through a dual-action mechanism—the corticosteroid component provides immediate anti-inflammatory benefits while the hyaluronic acid improves the viscoelastic properties of synovial fluid, enhancing joint lubrication and function over time.

Cingal® is primarily used for the treatment of symptomatic knee osteoarthritis. When natural hyaluronic acid levels in the synovial fluid decrease due to osteoarthritis, the joint loses its ability to effectively cushion and lubricate. 

Cingal® addresses this deficiency by supplementing the synovial fluid with cross-linked hyaluronic acid while simultaneously reducing inflammation. This comprehensive approach makes it an excellent option for patients who have failed to respond to conventional treatments and require both immediate pain relief and long-term functional improvement.

As a third-generation viscosupplementation solution from Anika Therapeutics, Cingal® represents the culmination of extensive research and clinical expertise in treating joint pain. Healthcare professionals choose Cingal® for its:

• Unique dual-action formula combining immediate and sustained relief
• Single-injection protocol that increases patient compliance and convenience
• Clinical evidence supports both the rapid onset and duration of effects
• Excellent safety profile with minimal adverse reactions
• Simple administration procedure requiring only one appointment

For medical professionals seeking to enhance their osteoarthritis treatment protocols, you can order Cingal® online through Kinami Health’s secure platform.

Clinical studies demonstrate that patients typically experience noticeable improvement within one week following a single Cingal® injection. The effects of this treatment can last up to six months, making it one of the longest-lasting viscosupplementation options available. 

Individual results may vary depending on the severity of osteoarthritis and patient-specific factors, but the combination of corticosteroid for immediate action and cross-linked hyaluronic acid for sustained benefit creates a comprehensive therapeutic approach with extended durability.

Cingal® has demonstrated an excellent safety profile in clinical trials and real-world applications. This product should only be administered by qualified healthcare professionals 

familiar with intra-articular injection techniques. 

Before treatment, patients should disclose any allergies, pregnancy status, or if they are nursing. As with any medical procedure, proper patient selection and adherence to aseptic injection techniques are essential for optimal outcomes and safety.